Literature DB >> 21937258

The role of the adenomatous polyposis coli (APC) in oral squamous cell carcinoma.

Mario Pérez-Sayáns1, José Manuel Suárez-Peñaranda, Michel Herranz-Carnero, Pilar Gayoso-Diz, Francisco Barros-Angueira, José Manuel Gándara-Rey, Abel García-García.   

Abstract

The main cause of death in oral squamous cell carcinomas (OSCC) is metastasis. Intercellular adhesion is mediated by a family of glycoproteins called cadherins and other molecules like catenins and APC (adenomatous polyposis coli) among other. The WNT (wingless-type) gene family is a group of genes, key signaling pathway for embryonic development and oncogenesis. The goal of this paper is to describe the role of the APC gene, and its derivatives, in the carcinogenicity pathway of WNT-1, identifying its role as a tumor suppressor gene in OSCC, while describing the genetic (loss of heterozygosity and mutations) and epigenetic alterations that modulate its expression and evaluate its relationship with the clinicopathological parameters of this type of tumors. As for APC, its activity as a tumor suppressor gene appears muted on a relatively frequent basis in these tumors, either by LOH, mutations or epigenetic control mechanisms, thus resulting in a low degree of agreement between the results of different studies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937258     DOI: 10.1016/j.oraloncology.2011.09.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

1.  N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration.

Authors:  Gangli Liu; Pritam K Sengupta; Basem Jamal; Hsiao-Ying Yang; Meghan P Bouchie; Volkhard Lindner; Xaralabos Varelas; Maria A Kukuruzinska
Journal:  J Biol Chem       Date:  2013-05-23       Impact factor: 5.157

Review 2.  Genetic alterations and clinical dimensions of oral cancer: a review.

Authors:  Keerthana Karunakaran; Rajiniraja Muniyan
Journal:  Mol Biol Rep       Date:  2020-10-21       Impact factor: 2.316

3.  Expression of APC protein during tongue malignant transformation in galectin-3-deficient mice challenged by the carcinogen 4-nitroquniline-n-oxide.

Authors:  Marcus Vinicius Rodrigues de Souza; João Paulo Silva Servato; Adriano Mota Loyola; Sérgio Vitorino Cardoso; Roger Chammas; Fu-Tong Liu; Marcelo José Barbosa Silva; Paulo Rogério de Faria
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

4.  Methylation-mediated molecular dysregulation in clinical oral malignancy.

Authors:  Rebecca Towle; Cathie Garnis
Journal:  J Oncol       Date:  2012-05-07       Impact factor: 4.375

5.  Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer.

Authors:  Camile B Lopes; Leandro L Magalhães; Carolina R Teófilo; Ana Paula N N Alves; Raquel C Montenegro; Massimo Negrini; Ândrea Ribeiro-Dos-Santos
Journal:  BMC Cancer       Date:  2018-07-06       Impact factor: 4.430

6.  Effective combinatorial immunotherapy for penile squamous cell carcinoma.

Authors:  Tianhe Huang; Xi Cheng; Jad Chahoud; Ahmed Sarhan; Pheroze Tamboli; Priya Rao; Ming Guo; Ganiraju Manyam; Li Zhang; Yu Xiang; Leng Han; Xiaoying Shang; Pingna Deng; Yanting Luo; Xuemin Lu; Shan Feng; Magaly Martinez Ferrer; Y Alan Wang; Ronald A DePinho; Curtis A Pettaway; Xin Lu
Journal:  Nat Commun       Date:  2020-05-01       Impact factor: 14.919

Review 7.  Wnt pathway in oral cancer: A review update.

Authors:  Nyi Mas Siti Purwaningsih; Goot Heah Khor; Nik Mohd Mazuan Nik Mohd Rosdy; Effat Omar Abdul Rahman
Journal:  Saudi Dent J       Date:  2021-08-05

8.  Lentivirus-based RNA silencing of Nemo-like kinase (NLK) inhibits the CAL 27 human adenosquamos carcinoma cells proliferation and blocks G0/G1 phase to S phase.

Authors:  Bin Zhang; Ke Yi Li; Hai Ying Chen; Shao Dong Pan; Shuang Feng Chen; Wei Feng Zhang; Chun Peng Xia; Li Cheng Jiang; Xian Bin Liu; Feng Jun Zhao; Dao Ying Yuan; Le Xin Wang; Ya Ping Wu; Shu Wei Liu
Journal:  Int J Med Sci       Date:  2013-08-08       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.